SCHEMBL24326976

SCHEMBL24326976

Cc1ccc(C)c2c1CCN2S(C)(=O)=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.38
MEN1 O00255 7/20 0.36
KMT2A Q03164 7/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
LMNA P02545 1/20 0.35
NPSR1 Q6W5P4 2/20 0.34
GLA P06280 1/20 0.34
POLB P06746 1/20 0.34
NPBWR1 P48145 1/20 0.33
MCHR1 Q99705 1/20 0.33
GPR55 Q9Y2T6 1/20 0.33
NOTUM Q6P988 1/20 0.33
HPGD P15428 1/20 0.33
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
CRHBP P24387 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24326971 0.86 NPSR1 (0.37) HTR2CMEN1KMT2ANPC1RAB9A
SCHEMBL24326968 0.86 HTR2C (0.35) HTR2CMEN1KMT2ANPC1RAB9A
SCHEMBL24327448 0.86 MEN1 (0.36) HTR2CMEN1KMT2ANPC1RAB9A
SCHEMBL24351831 0.85 HTR2C (0.40) HTR2CMEN1KMT2ANPC1RAB9A
SCHEMBL24351816 0.84 KDM4E (0.34) HTR2CMEN1KMT2ANPC1RAB9A
SCHEMBL24326972 0.84 HTR2C (0.40) HTR2CMEN1KMT2AL3MBTL1LMNA
SCHEMBL24351819 0.82 HTR2A (0.39) HTR2CMEN1KMT2ANPC1RAB9A
SCHEMBL24351832 0.82 HTR6 (0.41) HTR2CMEN1KMT2ANPC1RAB9A
SCHEMBL22312062 0.75 NOTUM (0.53) HTR2CMEN1KMT2ANPC1RAB9A
SCHEMBL14591313 0.75 ALOX12 (0.47) HTR2CMEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022068849-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF EGFR AND RELATED METHODS OF USE BEIGENE, LTD. (KY) 2022-04-07 WO disclosed
WO-2022063106-A1 INDOLINE COMPOUNDS AND DERIVATIVES AS EGFR INHIBITORS BEIGENE, LTD. (KY) 2022-03-31 WO disclosed